These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31474956)

  • 1. A Model Based on the Combination of IFN-γ, IP-10, Ferritin and 25-Hydroxyvitamin D for Discriminating Latent From Active Tuberculosis in Children.
    Comella-Del-Barrio P; Abellana R; Villar-Hernández R; Jean Coute MD; Sallés Mingels B; Canales Aliaga L; Narcisse M; Gautier J; Ascaso C; Latorre I; Dominguez J; Perez-Porcuna TM
    Front Microbiol; 2019; 10():1855. PubMed ID: 31474956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak.
    Hong Y; Kim Y; Lee JJ; Lee MG; Lee CY; Kim Y; Heo J; Han SS; Lee SJ; Kim WJ; Hong JY
    BMC Infect Dis; 2019 Feb; 19(1):151. PubMed ID: 30760247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
    Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
    PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.
    De Groote MA; Higgins M; Hraha T; Wall K; Wilson ML; Sterling DG; Janjic N; Reves R; Ochsner UA; Belknap R
    J Clin Microbiol; 2017 Feb; 55(2):391-402. PubMed ID: 27852671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: A systematic review and meta-analysis.
    Pourakbari B; Mamishi S; Benvari S; Mahmoudi S
    Adv Med Sci; 2019 Sep; 64(2):437-443. PubMed ID: 31586819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis.
    Lombardi G; Petrucci R; Corsini I; Bacchi Reggiani ML; Visciotti F; Bernardi F; Landini MP; Cazzato S; Dal Monte P
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.
    Wergeland I; Assmus J; Dyrhol-Riise AM
    PLoS One; 2016; 11(9):e0163848. PubMed ID: 27685462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.